These scholars and have demonstrated a commitment to not only excellence in impactful research, but in teaching, mentorship, and serving local and global communities.
Findings from the researchers’ study of the safety and efficacy of the vaccine were published this week in a peer-reviewed journal. Phase 2 trials are underway.
The new funding, through the Canadian Pandemic Preparedness Hub, supports the Fitzhenry Vector Lab and the Sartorius Bioprocess Automation Lab.